Daicel 将来の成長

Future 基準チェック /16

Daicel利益と収益がそれぞれ年間5%と7.2%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に13.4% 5.8%なると予測されています。

主要情報

5.0%

収益成長率

5.8%

EPS成長率

Chemicals 収益成長	17.1%
収益成長率	7.2%
将来の株主資本利益率	13.4%
アナリストカバレッジ	Good
最終更新日	15 Dec 2023

今後の成長に関する最新情報

Recent updates

業績と収益の成長予測

OTCPK:DACH.F - アナリストの将来予測と過去の財務データ ( )JPY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2026	633,350	52,525	36,906	90,274	6
3/31/2025	602,129	48,621	18,737	79,749	7
3/31/2024	563,183	52,220	1,000	85,264	6
9/30/2023	542,798	48,223	4,579	68,269	N/A
6/30/2023	540,847	46,763	N/A	N/A	N/A
3/31/2023	538,026	40,682	-25,076	26,847	N/A
12/31/2022	529,471	37,300	N/A	N/A	N/A
9/30/2022	509,352	31,418	-25,415	22,352	N/A
6/30/2022	484,560	27,874	N/A	N/A	N/A
3/31/2022	467,937	31,254	-4,478	42,993	N/A
12/31/2021	455,188	31,981	N/A	N/A	N/A
9/30/2021	443,039	38,486	22,506	64,419	N/A
6/30/2021	422,013	31,361	N/A	N/A	N/A
3/31/2021	393,568	19,713	21,080	57,869	N/A
12/31/2020	381,394	11,565	N/A	N/A	N/A
9/30/2020	377,491	-3,432	10,543	43,755	N/A
6/30/2020	391,855	291	N/A	N/A	N/A
3/31/2020	412,826	4,978	10,880	57,193	N/A
12/31/2019	420,714	6,873	N/A	N/A	N/A
9/30/2019	440,298	24,590	18,363	66,881	N/A
6/30/2019	453,221	30,214	N/A	N/A	N/A
3/31/2019	464,859	35,301	14,944	58,523	N/A
12/31/2018	474,189	41,656	N/A	N/A	N/A
9/30/2018	469,163	39,875	23,179	64,114	N/A
6/30/2018	466,197	38,361	N/A	N/A	N/A
3/31/2018	462,956	37,062	33,456	66,888	N/A
12/31/2017	463,050	39,388	N/A	N/A	N/A
9/30/2017	459,294	43,720	41,876	77,209	N/A
6/30/2017	448,646	41,746	N/A	N/A	N/A
3/31/2017	440,061	43,198	N/A	86,168	N/A
12/31/2016	430,450	38,733	N/A	N/A	N/A
9/30/2016	433,192	38,026	N/A	75,387	N/A
6/30/2016	440,131	39,233	N/A	N/A	N/A
3/31/2016	449,878	40,313	N/A	65,419	N/A
12/31/2015	452,851	39,110	N/A	N/A	N/A
9/30/2015	451,575	35,640	N/A	61,515	N/A
6/30/2015	448,714	33,739	N/A	N/A	N/A
3/31/2015	443,776	31,253	N/A	57,413	N/A
12/31/2014	443,623	29,850	N/A	N/A	N/A
9/30/2014	435,514	27,659	N/A	51,595	N/A
6/30/2014	427,412	25,589	N/A	N/A	N/A
3/31/2014	413,786	22,844	N/A	44,778	N/A
12/31/2013	396,045	22,608	N/A	N/A	N/A
9/30/2013	378,155	20,326	N/A	39,357	N/A
6/30/2013	365,412	17,984	N/A	N/A	N/A
3/31/2013	358,514	15,373	N/A	44,480	N/A
12/31/2012	352,481	13,631	N/A	N/A	N/A

アナリストによる今後の成長予測

収入対貯蓄率: DACH.Fの予測収益成長率 (年間5% ) は貯蓄率 ( 2.2% ) を上回っています。

収益対市場: DACH.Fの収益 ( 5% ) US市場 ( 15.2% ) よりも低い成長が予測されています。

高成長収益: DACH.Fの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: DACH.Fの収益 ( 7.2% ) US市場 ( 8.9% ) よりも低い成長が予測されています。

高い収益成長: DACH.Fの収益 ( 7.2% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: DACH.Fの自己資本利益率は、3年後には低くなると予測されています ( 13.4 %)。

Daicel 将来の成長

Future 基準チェック /16

主要情報

今後の成長に関する最新情報

Daicel Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2024 and Fiscal Year Ending March 31, 2025

Daicel Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023

Daicel Corporation Provides Consolidated Earnings Forecast for the First Half and Full Year of Fiscal Year Ending March 31, 2023

Recent updates

Daicel Corporation Declares Dividend for the Second Quarter End of the Fiscal Year 2025, Payable on December 3, 2024; Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2025

Daicel Corporation to Report Q2, 2025 Results on Nov 07, 2024

Daicel Corporation to Report Q1, 2025 Results on Aug 02, 2024

Daicel Corporation, Annual General Meeting, Jun 21, 2024

Daicel Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2024 and Fiscal Year Ending March 31, 2025

Daicel Corporation to Report Fiscal Year 2024 Results on May 09, 2024

Daicel Corporation to Report Q3, 2024 Results on Feb 06, 2024

Daicel Corporation (TSE:4202) announces an Equity Buyback for 13,000,000 shares, representing 4.55% for ¥15,000 million.

Daicel Corporation Declares Dividend for the Second Quarter End of the Fiscal Year 2024, Payable on December 4, 2023; Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024

Daicel Corporation to Report Q2, 2024 Results on Nov 02, 2023

Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire Healthcare Mail Order Business Of Daicel from Daicel Corporation (TSE:4202).

Daicel Corporation to Report Q1, 2024 Results on Aug 03, 2023

Daicel Corporation Announces Year End Dividend for the Year Ended March 31, 2023, Payable on June 26, 2023; Provides Dividend Guidance for the End of Second Quarter and Full Year Ending March 31, 2024

Daicel Corporation, Annual General Meeting, Jun 23, 2023

Daicel Corporation Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023

Daicel Corporation to Report Fiscal Year 2023 Results on May 11, 2023

Daicel Corporation to Report Q3, 2023 Results on Feb 02, 2023

Daicel Corporation Declares Dividend for the Second Quarter End of the Fiscal Year 2023, Payable on December 2, 2022; Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2023

Daicel Corporation (TSE:4202) announces an Equity Buyback for 12,000,000 shares, representing 4.05% for ¥10,000 million.

Daicel Corporation to Report Q2, 2023 Results on Nov 02, 2022

Daicel Corporation Provides Consolidated Earnings Forecast for the First Half and Full Year of Fiscal Year Ending March 31, 2023

Daicel Corporation to Report Q1, 2023 Results on Aug 04, 2022

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘